CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-15 | Mulligan Richard Director | Grant or award | +1,370 | 15,099 | ||
| 2021-07-01 | Mulligan Richard Director | Grant or award | +775 | 13,729 | ||
| 2020-06-03 | Mulligan Richard Director | Grant or award | +890 | 12,954 | ||
| 2019-06-19 | Mulligan Richard Director | Grant or award | +1,155 | 12,064 | ||
| 2018-06-12 | Mulligan Richard Director | Grant or award | +880 | 10,909 | ||
| 2017-06-07 | Mulligan Richard Director | Grant or award | +1,055 | 10,029 | ||
| 2016-06-08 | Mulligan Richard Director | Grant or award | +1,060 | 8,950 |
Page 1 of 1 · 7 trades